Related Experiment Videos

Acute and long lasting neurochemical effects of monosodium glutamate administration to mice

Neuropharmacology
|December 1, 1983
PubMed

Insights

Acute monosodium glutamate (MSG) administration alters hypothalamic monoamine metabolism and causes minor neuronal loss. These neurochemical changes in the brain may link to neuroendocrine effects.

Area of Science:

  • Neuroendocrinology
  • Neurochemistry
  • Neuropharmacology

Background:

  • Excitatory amino acids, like monosodium glutamate (MSG), can influence anterior pituitary hormone release.
  • Understanding the neurochemical impact of MSG is crucial for comprehending its neuroendocrine effects.

Purpose of the Study:

  • To investigate the neurochemical consequences of acute monosodium glutamate (MSG) administration in adult mice.
  • To determine the short-term (30 minutes) and long-term (60 days) effects of MSG on hypothalamic monoamine levels.

Main Methods:

  • Adult mice received an acute injection of monosodium glutamate (MSG) at a dose of 4 mg/g.
  • Hypothalamic levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindoleacetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenylglycol (MOPEG) were measured.
  • Neuronal counts in the ventral arcuate nucleus were assessed.

Main Results:

  • Thirty minutes post-MSG, hypothalamic DA and DOPAC increased by 27% and 25%, respectively.
  • Hypothalamic MOPEG levels rose by 75%, with a 34% increase in the whole brain.
  • Long-term effects included a slight loss of neurons in the ventral arcuate nucleus and a 21% reduction in hypothalamic 5-HIAA.

Conclusions:

  • Acute MSG administration significantly alters hypothalamic monoamine metabolism.
  • These neurochemical alterations may underlie the neuroendocrine effects observed after excitatory amino acid exposure.
  • Long-term consequences are subtle, involving minor neuronal loss and reduced 5-HIAA levels.

Related Concept Videos